跳至主要内容
临床试验/NCT03697369
NCT03697369已完成不适用

Glycemic Control and Treatment Satisfaction in Children With Type 1 Diabetes Using Insulin Pumps

Assaf-Harofeh Medical Center0 个研究点目标入组 60 人开始时间: 2015年5月31日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
60
主要终点
Discontinuation rate differences

研究概览

简要总结

Background: The use of insulin pumps in pediatric patients with type 1 diabetes(T1D) has expanded, with lack of data comparing between the different devices.

Objective: to compare prospectively glycemic control, technical difficulties and quality of life (QOL) between 3 pump devices during the first year of use .

Methods: a prospective observational trial, based on clinical data retrieved during 12 months of follow- up. Inclusion criteria included T1D patients, ages 1-18 years, who started pump therapy as part of their clinical care in 4 university affiliated medical centers. The devices fully reimbursed by national health insurance are: MiniMed™ 640G , MiniMed® Veo™, Animas® Vibe®, and Abbott Omnipod®. Comparison parameters included quality of life (QOL), frequency of technical difficulties, skin reactions, discontinuation rate, glycated hemoglobin (HBA1C), mean glucose, total daily insulin dose (TDD) , pump setting parameters and BMI.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
— 至 21 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of T1D recorded by a pediatric endocrinologist
  • Attending periodic clinic visits, and starting pump mode of therapy between May 2015 and March 2017.

排除标准

  • No restrictions on HbA1c value at study recruitment or on use of CGMS -

结局指标

主要结局

Discontinuation rate differences

时间窗: 2 years from patient first enrollment

Comparison between constant pump users and those who discontinued

Technical difficulties differences

时间窗: 2 years from patient first enrollment

All patients were asked 5 questions regarding monthly frequency of technical problems including the need to use extra sets and the level of pain at catheter insertion

Quality Of Life (QOL)

时间窗: 2 years from patient first enrollment

QOL assessment was performed utilizing The Diabetes Treatment Satisfaction Questionnaires (DTSQ) for teens and for parents, separately \[14\]. The teens DTSQ contained 12 items scores on six-point scales, of which 9 were summed, the parents DTSQ contained 14 items, of which 9 were summed. Maximal grade was 42.

Skin reactions differences

时间窗: 2 years from patient first enrollment

skin assessment at the pump insertion site (itching and redness).

次要结局

  • Glycemic control and metabolic parameters differences: HbA1c%(2 years from patient first enrollment)
  • Glycemic control and metabolic parameters differences:Number of SMBG per day(2 years from patient first enrollment)
  • Glycemic control and metabolic parameters differences:BMI SDS(2 years from patient first enrollment)
  • Glycemic control and metabolic parameters differences: Insulin TDD(2 years from patient first enrollment)
  • Glycemic control and metabolic parameters differences:Glucose Mean & SD(2 years from patient first enrollment)

研究者

申办方类型
Other Gov
责任方
Sponsor

相似试验